In 2017, oral direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection became available free of charge for all HCV-RNA-positive patients, irrespective of their fibrosis stage.
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy
Cacopardo, Bruno;
2018-01-01
Abstract
In 2017, oral direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection became available free of charge for all HCV-RNA-positive patients, irrespective of their fibrosis stage.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Characteristics of patients with hepatitis C.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
182.26 kB
Formato
Adobe PDF
|
182.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
